2 hours ago
Abbott (ABT) Finalizes $21 Billion Exact Sciences (EXAS) Takeover
Abbott closes $21B acquisition of Exact Sciences (EXAS) at $105/share. EXAS delisted from Nasdaq on March 23, 2026, becoming Abbott subsidiary.
The post Abbott (ABT) Finalizes $21 Billion Exact Sciences (EXAS) Takeover appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
CRCL Stock Drops 18% as USDC Activity Jumps 600%
- 2 hours ago
Circle Internet Group (CRCL) Stock Plunges 15.64% as USDC Enters African Markets
- 2 hours ago
Fundrise Innovation Fund (VCX) Stock Surges Over 740% Amid AI Frenzy
- 2 hours ago
Grab (GRAB) Stock Jumps Nearly 5% on $400M Share Repurchase Plan
- 2 hours ago
Jensen Huang’s Bold AGI Declaration: What Nvidia’s (NVDA) CEO Really Meant